These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26511338)

  • 1. Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations.
    Dean B; Hopper S; Conn PJ; Scarr E
    Neuropsychopharmacology; 2016 May; 41(6):1620-8. PubMed ID: 26511338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widespread Changes in Positive Allosteric Modulation of the Muscarinic M1 Receptor in Some Participants With Schizophrenia.
    Hopper S; Pavey GM; Gogos A; Dean B
    Int J Neuropsychopharmacol; 2019 Oct; 22(10):640-650. PubMed ID: 31428788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1.
    Dean B; Soulby A; Evin GM; Scarr E
    Schizophr Res; 2008 Dec; 106(2-3):229-36. PubMed ID: 18790604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of the factors that regulate muscarinic receptor expression in schizophrenia.
    Seo MS; Scarr E; Dean B
    Schizophr Res; 2014 Sep; 158(1-3):247-54. PubMed ID: 25037527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia.
    Scarr E; Cowie TF; Kanellakis S; Sundram S; Pantelis C; Dean B
    Mol Psychiatry; 2009 Nov; 14(11):1017-23. PubMed ID: 18317461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype.
    Salah-Uddin H; Scarr E; Pavey G; Harris K; Hagan JJ; Dean B; Challiss RA; Watson JM
    Neuropsychopharmacology; 2009 Aug; 34(9):2156-66. PubMed ID: 19404243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulators and selective agonists of muscarinic receptors.
    Holzgrabe U; De Amici M; Mohr K
    J Mol Neurosci; 2006; 30(1-2):165-8. PubMed ID: 17192667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Widespread decreases in cortical muscarinic receptors in a subset of people with schizophrenia.
    Gibbons AS; Scarr E; Boer S; Money T; Jeon WJ; Felder C; Dean B
    Int J Neuropsychopharmacol; 2013 Feb; 16(1):37-46. PubMed ID: 22338582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
    Norman AB; Eubanks JH; Creese I
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1116-22. PubMed ID: 2703964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.
    Krejcí A; Tucek S
    Mol Pharmacol; 2001 Oct; 60(4):761-7. PubMed ID: 11562438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of tissue integrity on pharmacological phenotypes of muscarinic acetylcholine receptors in the rat cerebral cortex.
    Md Anisuzzaman AS; Nishimune A; Yoshiki H; Uwada J; Muramatsu I
    J Pharmacol Exp Ther; 2011 Oct; 339(1):186-93. PubMed ID: 21719469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors.
    Flynn DD; Vaishnav AA; Mash DC
    Mol Pharmacol; 1992 Apr; 41(4):736-42. PubMed ID: 1569924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of orthosteric and allosteric ligands with [3H]dimethyl-W84 at the common allosteric site of muscarinic M2 receptors.
    Tränkle C; Weyand O; Voigtländer U; Mynett A; Lazareno S; Birdsall NJ; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):180-90. PubMed ID: 12815174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.
    Voigtländer U; Jöhren K; Mohr M; Raasch A; Tränkle C; Buller S; Ellis J; Höltje HD; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):21-31. PubMed ID: 12815157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of a modified [3H]4-DAMP radioligand binding assay with increased selectivity for muscarinic M3 receptor shows that cortical CHRM3 levels are not altered in mood disorders.
    Jeon WJ; Gibbons AS; Dean B
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():7-12. PubMed ID: 23962466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower levels of cortical [
    Dean B; Haroutunian V; Scarr E
    Schizophr Res; 2023 May; 255():274-282. PubMed ID: 37079947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA.
    Scarr E; Craig JM; Cairns MJ; Seo MS; Galati JC; Beveridge NJ; Gibbons A; Juzva S; Weinrich B; Parkinson-Bates M; Carroll AP; Saffery R; Dean B
    Transl Psychiatry; 2013 Feb; 3(2):e230. PubMed ID: 23423139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of a kinetic model to the apparently complex behavior of negative and positive allosteric modulators of muscarinic acetylcholine receptors.
    Avlani V; May LT; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1062-72. PubMed ID: 14711931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction studies of multiple binding sites on m4 muscarinic acetylcholine receptors.
    Lanzafame AA; Sexton PM; Christopoulos A
    Mol Pharmacol; 2006 Aug; 70(2):736-46. PubMed ID: 16709648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor.
    Mistry SN; Valant C; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2013 Jun; 56(12):5151-72. PubMed ID: 23718562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.